CardiAMP HF II is Evaluating the CardiAMP™ Cell Therapy Product for Treating Patients with Ischemic Heart Failure of Reduced Ejection Fraction ...

SUNNYVALE, Calif., April 11, 2025 (GLOBE NEWSWIRE) -- BioCardia, Inc. [Nasdaq: BCDA], a global leader in cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary ...

“Dr. Quyyumi's significant expertise in these trials and inspiring leadership, coupled with the world-class capabilities at Emory University School of Medicine, a leading institution in the ...

Hydroxyurea remains effective long-term in reducing emergency department visits and hospital days for children living with ...

“No patient with myeloma should die without seeing a bispecific,” declared Nisha Joseph, MD, associate professor, Department of Hematology and Medical Oncology, Emory School of Medicine.

and assistant professor in the Department of Pediatrics at Emory University School of Medicine. For this study, Qiu also developed the hydrogel for this model using human blood in a human vein ...

Key Takeaways. Layoffs at the U.S. Centers for Disease Control and Prevention included all 27 staff at the viral hepatitis ...